entertainment -WSS

entertainment

author：comprehensive 2025-10-01 23:00:10 - browse：6

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Ukraine taking heavy casualties 10 weeks into its counteroffensive

WSS

An interview with Robert F. Kennedy Jr. on vaccines

Extreme heat events are a public health emergency

White House calls on federal agencies to crack down on AI abuses

The new shift in health care is toward less care

Free speech concerns arise in wake of journal editor Eisen's firing

More doctors should go into startup world

explore

entertainment

focus

Virginia high school admissions case could be legal follow

Extreme heat events are a public health emergency

Medicare proposal to cover medical devices draws a mixed reaction

ProMED sees offers of support, but its future remains unclear

Medical leaders decry Supreme Court decision on affirmative action

Living with Hashimoto's and celiac disease, and med school, too

Guidelines to prevent youth baseball injuries need more muscle

FDA approves potent Eli Lilly obesity drug, Zepbound

Cancer drug shortages should be causing more outrage

Patient advocates sound warning on FDA proposal on salt intake

explore

More doctors should go into startup world

Clinical trials must include more disabled people

Study: New antibiotic targets gonorrhea as well as last existing drug

Free speech concerns arise in wake of journal editor Eisen's firing

Removing probiotics from the NICU could threaten preemies' health

Hilary may become 1st tropical storm to make landfall in California in 84 years

hotspot

focus

focus

leisure time